Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive - Test2 - elhamkhani - TriplyDB

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

http://www.wikidata.org/entity/Q28748178

about

sameAs

Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke.Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials The exact science of stroke thrombolysis and the quiet art of patient selection Reperfusion therapies for acute ischemic stroke: an update Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analy Intravenous thrombolysis for acute ischaemic stroke in the elderly: data from the Baden-Wuerttemberg stroke registry.Clinical Outcome after Intra-Arterial Stroke Therapy in the Very Elderly: Why is it so Heterogeneous?Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.Development, expansion, and use of a stroke clinical trials resource for novel exploratory analyses.Intravenous thrombolysis with recombinant tissue plasminogen activator for ischemic stroke patients over 80 years old: the Fukuoka Stroke Registry How baseline severity affects efficacy and safety outcomes in acute ischemic stroke intervention trials.[Industry-funded therapy studies: what is in the pipeline?].Postthrombolysis outcomes in acute ischemic stroke patients of Asian race-ethnicity.The effect of time to treatment on outcome in very elderly thrombolysed stroke patients.Stroke in the very old: a systematic review of studies on incidence, outcome, and resource use.The case for an elderly targeted stroke management.Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.Safety and Efficacy of Thrombolytic Therapy Using rt-PA (Alteplase) in Acute Ischemic Stroke.Safety of thrombolysis in patients over the age of 80 The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era The impact of intravenous thrombolysis on outcome of patients with acute ischemic stroke after 90 years old.Intravenous thrombolytic treatment in the oldest old.Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience.Intravenous Thrombolysis is Effective in Young Adults: Results from the Baden-Wuerttemberg Stroke Registry.Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke.Outcome after systemic thrombolysis is predicted by age and stroke severity: an open label experience with recombinant tissue plasminogen activator and tirofiban.Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100 Effectiveness of alteplase in the very elderly after acute ischemic stroke Stroke Outcomes in Thai Elderly Patients Treated with and without Intravenous Thrombolysis Evolving prehospital, emergency department, and "inpatient" management models for geriatric emergencies.Endovascular therapy in acute ischemic stroke: where we are, the challenges we face and what the future holds.How to make better use of thrombolytic therapy in acute ischemic stroke.Interventional stroke therapies in the elderly: are we helping?Pharmacokinetics of alteplase in the treatment of ischaemic stroke.Plasminogen activation and thrombolysis for ischemic stroke.The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals.Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.Elderly patients and intra-arterial stroke therapy.

P2860

Q24595703-60BAF37B-537B-4E65-A751-877EAFC89B9E Q26796474-35A3290B-5152-4C6D-8F76-F161CED1AEFA Q26823902-6CF050C7-DE88-4EBE-BE50-5EB1D1B96A9A Q27011873-00049242-1F4E-4AC1-A0F9-3A33DB5AB351 Q30399762-BB438266-7065-4B37-B359-E670F43F68F6 Q30414441-97D3470D-3D86-4F07-80B4-C7CF045D8979 Q30620870-B4EDCDD0-2964-4604-8020-F3AEE2223BFC Q31009812-F247C4D9-F29F-4ECF-A4ED-2630F301D485 Q33569164-8A1A04A4-8342-4C48-BAD6-115D48716ED3 Q34006140-CC9D8909-CFF5-45F4-9B44-3CCF8774D96D Q34134653-E342ABB2-75B2-487F-B2ED-BDD2A4CB72E4 Q34352226-C2067AC3-861E-4F9D-BDF5-F22773A90574 Q34418517-FA1E1B13-03EC-4FBF-98F6-EF1F93319044 Q34439773-BE02724E-03D5-49C5-96B3-C45E74348164 Q34620268-01779029-7DFA-43F4-8BE0-76A51C272635 Q35109405-F59A683A-B85D-42B4-B47F-C08ED2A71146 Q35179656-36F6ED58-57EE-4F0C-97EF-043DFDBC0EBC Q35641960-B1DDB67D-44E9-435B-B86B-8930C6B30BD2 Q35671209-EBAD15D3-FEE4-4368-9403-E517CE83FA1A Q35687245-A28A9C90-2A6C-4F4B-924D-5EBBE61C2EE2 Q35799271-4B6EA21C-23F7-43B1-9BFE-3E677EF98103 Q35943820-D27ECB4B-8F1C-4618-8C65-C5B8888FEA7C Q36113608-FDBEFAD4-F809-4FD1-8297-29A593E6E1D4 Q36119123-CF5E681F-FF14-4625-820D-1560047F38F4 Q36195506-01FD85DA-E454-4209-A962-E40E5638CD57 Q36245563-766895A7-4D75-4FA6-A310-BE2B8F041EFF Q36255802-4214C025-8B72-48F1-8B98-B4A98E5F256E Q36375658-5B9D4091-7208-4C52-AEED-497692D857E2 Q36659436-F5000BBA-F270-4A88-BFD7-DCC1EF754020 Q37088533-7F51399E-291A-4B4D-8EA5-3AC1E8579FB0 Q37224387-6095E2EC-70F7-4D90-8FEE-A6431F333D75 Q37420279-5B7080AF-1849-41B1-AB7E-05D336A69175 Q37868579-B2FF4FB7-1BE7-4F93-ADFB-19BA3CE9D4CB Q37889116-B54D2A32-FCC9-4BFE-A43F-B10E3409037E Q37960763-D69C84D0-0B93-47E9-AEC1-5D4130ED821C Q37976123-6588F1CD-A3C4-4E5B-94DC-F65C434D9D37 Q37998537-F9FA0706-0728-499B-AB97-698F1D159A11 Q38019965-33E1B415-11EA-49F4-8442-EC6FE2AB7ED4 Q38075828-AE7E6F89-DC57-4FA0-878B-021D99654761 Q38160242-DCCBBAA8-7037-4910-9DEA-9E4FFB9D4673

P2860

Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive

http://www.wikidata.org/entity/Q28748178

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@ast

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@en

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@nl

type

label

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@ast

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@en

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@nl

prefLabel

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@ast

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@en

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@nl

P1433

Q28748178-6B5B23A4-6465-4E1F-BA8E-FE7F8D314A92

P1476

Q28748178-C5378C27-4354-44DC-855C-9241F608155D

P2093

Q28748178-2336DAEA-60F6-4D30-B6ED-42117737C28F

Q28748178-3A1FD96D-3F3C-4AF7-92C1-598CA4D96800

Q28748178-41F808B0-50FF-4507-87B4-624DC61B041F

Q28748178-9495A482-3B6B-4175-8E0A-578995AF8D32

Q28748178-FE96C736-1154-40BF-B4E9-D79FEE20A67C

Q28748178-FFB9C08E-0D1B-40AD-A53A-20A40F792AF4

P2860

Q28748178-071B9FDE-EBA2-4A4A-BE6B-59AC104F1249

Q28748178-167FBC7C-4FD1-4BB2-9B6C-A3BEE41D66D4

Q28748178-16E7F037-F5B6-41C8-8062-ADF671881033

Q28748178-17162255-44A8-495F-A693-EC5660774C3B

Q28748178-1DA34968-38BA-4831-BC1B-372E34B782F9

Q28748178-1E8DCCF9-4903-4330-BD83-FC1F54A96166

Q28748178-1ED70693-36AC-436E-96A6-3E7A4980D6AA

Q28748178-206E0F5A-05A9-42B1-9AD9-8E001E519432

Q28748178-21378BC3-9EFA-43C2-ABA0-74440F96C53B

Q28748178-21385D2C-54B4-4E08-8E63-A577DD93CCD8

P304

Q28748178-70FCA6DF-92D9-4375-8D39-A1BBEC875BBA

P31

Q28748178-FF8414BB-B7B7-40FE-B5C4-32CB35C0AB5E

P3181

Q28748178-6CD30108-796F-45F2-AE30-D49049ECB0CE

P356

Q28748178-EF21E118-74D4-4D90-AEEE-1C732030E34C

P407

Q28748178-00EB6826-4528-4B51-B539-9856D57E99A8

P433

Q28748178-3F0FAB0D-7250-496E-9324-BAEC4B00E312

P478

Q28748178-FCBF4BFF-F7ED-46D7-912B-2E69B0BE4E46

P50

Q28748178-878FA280-EF55-469D-8C1C-D8A74CA7237A

Q28748178-8A096CC9-5F30-42CE-8339-3785BC6D4549

Q28748178-CF83BF79-F100-4CFA-819E-0E6F61BE2D8D

Q28748178-F6C2E38D-9448-4140-A4F0-38F0AE2589B5

P577

Q28748178-C86830EA-CA0E-431C-B671-3344C1C9FE74

P5875

Q28748178-10F8A75D-2FCD-4322-BB65-D3FD54C00819

P698

Q28748178-5B17997B-FFBE-49B4-B737-62BD8D4AF4C3

P921

Q28748178-3794AF89-CDF1-4761-B8EC-BECE9596D100

P932

Q28748178-C78CAC74-21E8-4ED6-B157-C60113546379

P3181

P356

P1433

P1476

Thrombolysis in very elderly p ...... national Stroke Trials Archive

@en

P2093

José A Egido

http://www.w3.org/2001/XMLSchema#string

Kennedy R Lees

http://www.w3.org/2001/XMLSchema#string

Nils G Wahlgren

http://www.w3.org/2001/XMLSchema#string

Nishant K Mishra

http://www.w3.org/2001/XMLSchema#string

SITS collaborators

http://www.w3.org/2001/XMLSchema#string

VISTA collaborators

http://www.w3.org/2001/XMLSchema#string

P2860

Additional outcomes and subgroup analyses of NXY-059 for acute ischemic stroke in the SAINT I trial

NXY-059 for acute ischemic stroke

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

Tissue plasminogen activator for acute ischemic stroke

Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials.

Stroke outcome in clinical trial patients deriving from different countries.

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA).

Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA).

Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models.

P304

c6046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3895126

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.C6046

http://www.w3.org/2001/XMLSchema#string

P407

P433

nov23 1

http://www.w3.org/2001/XMLSchema#string

P478

341

http://www.w3.org/2001/XMLSchema#string

P50

Peter A Ringleb

Perttu Lindsberg

Grethe Andersen

P577

2010-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49629750

http://www.w3.org/2001/XMLSchema#string

P698

21098614

http://www.w3.org/2001/XMLSchema#string

P921

P932

2990864

http://www.w3.org/2001/XMLSchema#string